Jarrad Mattieu Aguirre

LYEL

Jarrad Mattieu Aguirre serves as officer: Chief Medical Officer at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$3.6K

Net Position

Net Seller

$3.6K

Companies Traded

LYEL

Active Period

Oct 2026

1 total trades

Most Recent

Sell LYEL

Oct 13, 2026 · $3.6K

Jarrad Mattieu Aguirre's Insider Trading at Lyell Immunopharma, Inc. (LYEL)

Buys

0 · $0.00

Sells

1 · $3.6K

Total Shares Bought

Total Shares Sold

422

LYEL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 13, 2026	Sell	422	$8.63	$3.6K	19,857

Related Insiders

David Shook

officer: Chief Medical Officer

LYELSell · Sep 10, 2026

Gary K. Lee

officer: Chief Scientific Officer

LYELSell · Aug 25, 2026

Stephen J. Hill

officer: Chief Operating Officer

LYELSell · Aug 25, 2026

Lynn Seely

President and CEO

LYELSell · Aug 25, 2026

Veronica Sanchez Bulis

VP, Corporate Controller

LYELSell · Aug 11, 2026

Innovative Cellular Therapeutics Holdings Ltd

10 percent owner

LYELSell · Jul 20, 2026

ARCH Venture Fund XIII, L.P.

10 percent owner

LYELBuy · Mar 9, 2026

ARCH Venture Partners IX, LLC

10 percent owner

LYELBuy · Mar 9, 2026

Explore More Insider Trading Data

LYEL Insider Trading Activity

View all insider trades at Lyell Immunopharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity